These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38680699)

  • 1. Application and management of continuous glucose monitoring in diabetic kidney disease.
    Zhang XM; Shen QQ
    World J Diabetes; 2024 Apr; 15(4):591-597. PubMed ID: 38680699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic Kidney Disease: Is There a Role for Glycemic Variability?
    Subramanian S; Hirsch IB
    Curr Diab Rep; 2018 Feb; 18(3):13. PubMed ID: 29450720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?
    Bomholt T; Kofod D; Nørgaard K; Rossing P; Feldt-Rasmussen B; Hornum M
    Nephron; 2023; 147(2):91-96. PubMed ID: 35830847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.
    Ling J; Ng JKC; Chan JCN; Chow E
    Front Endocrinol (Lausanne); 2022; 13():869899. PubMed ID: 35528010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of HbA1c, Glycated Albumin and Continuous Glucose Monitoring to Assess Glucose Control in the Chronic Kidney Disease Population Including Dialysis.
    Bomholt T; Adrian T; Nørgaard K; Ranjan AG; Almdal T; Larsson A; Vadstrup M; Rix M; Feldt-Rasmussen B; Hornum M
    Nephron; 2021; 145(1):14-19. PubMed ID: 33264783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
    Galindo RJ; Beck RW; Scioscia MF; Umpierrez GE; Tuttle KR
    Endocr Rev; 2020 Oct; 41(5):756-74. PubMed ID: 32455432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of glucose management indicator derived from continuous glucose monitoring to assess glycemic condition in hospitalized patients with diabetic kidney disease treated with insulin pumps.
    Lu Y; Zhang Q; Wang X; Jiang Y; Xue Y
    J Diabetes Complications; 2023 Nov; 37(11):108613. PubMed ID: 37769507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
    Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T; Peng L; Umpierrez GE
    Diabetes Care; 2024 Feb; 47(2):267-271. PubMed ID: 38085705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of different glycemic control metrics for optimizing management of diabetes.
    Kohnert KD; Heinke P; Vogt L; Salzsieder E
    World J Diabetes; 2015 Feb; 6(1):17-29. PubMed ID: 25685275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of continuous glucose monitoring for type 2 in diabetes management and research.
    Vigersky R; Shrivastav M
    J Diabetes Complications; 2017 Jan; 31(1):280-287. PubMed ID: 27818105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic pattern in diabetic patients on hemodialysis: continuous glucose monitoring (CGM) analysis.
    Gai M; Merlo I; Dellepiane S; Cantaluppi V; Leonardi G; Fop F; Guarena C; Grassi G; Biancone L
    Blood Purif; 2014; 38(1):68-73. PubMed ID: 25300368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control.
    Yoo JH; Kim JH
    Diabetes Metab J; 2020 Dec; 44(6):828-839. PubMed ID: 33389957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making sense of glucose sensors in end-stage kidney disease: A review.
    Williams ME; Steenkamp D; Wolpert H
    Front Clin Diabetes Healthc; 2022; 3():1025328. PubMed ID: 36992784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.